P1733Fibroblast growth factor-23 (FGF23), an early biomarker of sublinical kidney dysfunction, is associated with poor prognosis in acute coronary syndrome patients | Zendy

AI Assistant Blog Pricing

P1733Fibroblast growth factor-23 (FGF23), an early biomarker of sublinical kidney dysfunction, is associated with poor prognosis in acute coronary syndrome patients

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.